Characteristic | Sub-group | Local anaesthetic group | Standard group | P-value |
---|---|---|---|---|
Number of patients | 30 | 30 | - | |
Age, years, mean | 47.6 | 48.0 | 0.88 | |
Height, m, mean | 1.66 | 1.66 | 0.78 | |
Weight, kg, mean | 60.9 | 62.5 | 0.56 | |
Body mass index, kg/m2, mean | 22.2 | 22.6 | 0.61 | |
ASA score | 1 | 10 | 15 | 0. 44 |
2 | 19 | 14 | ||
3 | 1 | 1 | ||
Associated diseases, n | 15 | 14 | 1.0 | |
Smoker, n | 9 | 10 | 0.93 | |
Diabetes mellitus, n | 0 | 0 | - | |
Fibromyalgia, n | 0 | 0 | - | |
Rheumatoid arthritis, n | 0 | 0 | - | |
Depression, n | 3 | 1 | 0.61 | |
Mastectomy side | Left n | 7 | 15 | 0.10 |
Right n | 15 | 10 | ||
Both n | 8 | 5 | ||
Tumour diameter, cm, mean (range) | 1.2 (0 to 5) | 1.3 (0 to 6.5) | 0.76 | |
Histology (n = 60) | Invasive ductal carcinoma, n | 22 | 17 | 0.56 |
Invasive lobular carcinoma, n | 2 | 2 | ||
Ductal in situ, n | 1 | 2 | ||
Without carcinoma, n | 5 | 9 | ||
Grade (n = 58) | Grade 0, n | 5 | 9 | 0.66 |
Grade I, n | 2 | 1 | ||
Grade II, n | 11 | 9 | ||
Grade III, n | 11 | 10 | ||
Metastatic lymph nodes, median (range) | 0 (0 to 21) | 0 (0 to 18) | 0.98 | |
Resected lymph nodes, median (range) | 2 (0 to 33) | 3 (0 to 27) | 0.97 | |
Hormone receptor-positive n | 18 | 20 | 0.79 | |
HER-2-positive n | 5 | 7 | 0.75 |